NASDAQ : BOLT

Bolt Biotherapeutics, Inc. — Key statistics

Healthcare · Biotechnology · United States

Last price 6.36 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.25M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

Measure	Value
Market Cap	12.69M
Enterprise Value	n/a

Dates

Measure	Value
Earnings Date	Nov 16, 2026
Ex-Dividend Date	n/a

Shares

Measure	Value
Current Share Class	n/a
Shares Outstanding	1.93M
Shares Change (YoY)	-8.42%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	3.78%
Owned by Institutions (%)	0.68%
Float	1.85M

Ratios

Measure	Value
PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Evratios

Measure	Value
EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financialposition

Measure	Value
Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financialefficiency

Measure	Value
Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	8.75%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	23
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Measure	Value
Income Tax	n/a
Effective Tax Rate	n/a

Stockprice

Measure	Value
Beta (5Y)	0.82
52-Week Price Change	+9.83%
50-Day Moving Average	3.88
200-Day Moving Average	4.50
Relative Strength Index (RSI)	81.35
Average Volume (20 Days)	685,492

Shortselling

Measure	Value
Short Interest	15,751
Short Previous Month	25,736
Short % of Shares Out	0.82%
Short % of Float	0.85%
Short Ratio (days to cover)	0.45

Incomestatement

Measure	Value
Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balancesheet

Measure	Value
Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cashflow

Measure	Value
Operating Cash Flow	-31.45M
Capital Expenditures	-85,000
Depreciation & Amortization	919,000
Net Borrowing	n/a
Free Cash Flow	-31.54M
FCF Per Share	-$16.37

Margins

Measure	Value
Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends

Measure	Value
Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	8.42%
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	-248.42%

Analystforecasts

Measure	Value
Price Target	$41.00
Price Target Difference	522.16%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (3Y)	1.98%
EPS Growth Forecast (3Y)	n/a

Stocksplits

Measure	Value
Last Split Date	Jun 9, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Measure	Value
Altman Z-Score	n/a
Piotroski F-Score	n/a

Fairvalue

Measure	Value
Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a